What is SENS's health score?

Senseonics Holdings, Inc. (SENS) has a TradeApes health score of 40 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is SENS's estimated fair value?

Based on our 5-year discounted cash flow model, Senseonics Holdings, Inc.'s estimated fair value is $0.79 per share, representing a -84.6% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is SENS undervalued or overvalued?

Our model currently rates SENS as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

1 free score card remaining

Senseonics Holdings, Inc. (SENS)

Healthcare Overvalued low weak

$5.13

Updated: 2026-07-14

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

53 Mixed

Relative Value

40 Weak

Capital Allocation

10 Stressed

Risk Management

35 Weak

Est. Fair Value $0.79

DCF Upside -84.6%

Sector Rank #5046 of 12117

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Industry Related Stocks

AGILENT TECHNOLOGIES, INC. (A) ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Aardvark Therapeutics, Inc. (AARD) AUTOSCOPE TECHNOLOGIES CORP (AATC) Abivax S.A. (AAVXF) Ascend Wellness Holdings, Inc. (AAWH)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.